Search - tctmd.com

Displaying 81 - 100 of 457

Sort: Relevancy | Date

Balloon-Expandable Redo TAVI Shows Promise in Real-world Cohort

News Daily News

Balloon-Expandable Redo TAVI Shows Promise in Real-world Cohort

Yael L. Maxwell

September 06, 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

News Conference News TVT 2023

‘Excellent’ Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Michael O'Riordan

June 09, 2023

SAPIEN 3 TAVR Durability

Presentation TVT 2023

SAPIEN 3 TAVR Durability

Presenter: Karim Al-Azizi

June 09, 2023

What Do We Actually Know About Bioprosthetic Valve Durability (SAVR and TAVR)

Presentation TVT 2023

What Do We Actually Know About Bioprosthetic Valve Durability (SAVR and TAVR)

Presenter: Danny Dvir

June 08, 2023

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

News Conference News EuroPCR 2023

Five-Year PORTICO IDE Data Reassure on Outcomes, Hemodynamics

Michael O'Riordan

May 17, 2023

Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients

News Conference News ACC 2023

Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients

March 05, 2023

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

News Conference News CRT 2023

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

Yael L. Maxwell

March 03, 2023

FDA Alert: Possible Early Deterioration of Abbott Trifecta SAVR Valves

News Daily News

FDA Alert: Possible Early Deterioration of Abbott Trifecta SAVR Valves

February 27, 2023

Patient Risk, Follow-up Duration Drive SAVR, TAVI Outcomes: Meta-analysis

News Daily News

Patient Risk, Follow-up Duration Drive SAVR, TAVI Outcomes: Meta-analysis

January 20, 2023

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

News Features

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Michael O'Riordan

January 06, 2023

Top Structural Heart News of 2022

News Daily News

Top Structural Heart News of 2022

January 06, 2023

Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review

News Daily News

Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review

December 28, 2022

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

News Conference News PCR London Valves 2022

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

December 07, 2022

Registry Results See Less PVL, Pacemakers With Acurate neo2

News Conference News PCR London Valves 2022

Registry Results See Less PVL, Pacemakers With Acurate neo2

November 29, 2022

Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains

News Conference News PCR London Valves 2022

Earlier Interventions and Later Redos? ‘Mature’ TAVI Still Has Growing Pains

November 28, 2022

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

News Daily News

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

November 21, 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

September 23, 2022

Valve Fracture for ViV TAVI Linked With Higher Mortality

News Conference News TCT 2022

Valve Fracture for ViV TAVI Linked With Higher Mortality

Michael O'Riordan

September 22, 2022

Bioprosthetic Valve Failure and Durability—Does TAVR Really Outperform SAVR?

Presentation TCT 2022

Bioprosthetic Valve Failure and Durability—Does TAVR Really Outperform SAVR?

Presenter: Michael Reardon

September 19, 2022

Considerations of TAVR and SAVR by age in the US including a clinically relevant definition of Bioprosthetic Durability

Presentation TCT 2022

Considerations of TAVR and SAVR by age in the US including a clinically relevant definition of Bioprosthetic Durability

Presenter: Evelio Rodriguez

September 18, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.